Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 827 | 0 | 0 | 0 | 0 |
| Gross Profit | 827 | N/A | N/A | N/A | N/A |
| Operating Expenses | 34,743 | 10,473 | 7,749 | 4,089 | -63,218 |
| Operating Income | -33,916 | -10,473 | -7,749 | -4,089 | 49,593 |
| Interest Expense | 2 | 0 | 0 | 0 | 0 |
| Other Income | -17,998 | -8,344 | 6 | -1,060 | -30,833 |
| Pre-tax Income | -51,916 | -18,817 | -7,743 | -5,149 | 18,760 |
| Income Tax | -2,003 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -49,913 | -18,817 | -7,743 | -5,149 | 16,438 |
| Net Income | $-49,913 | $-18,817 | $-7,743 | $-5,149 | $16,438 |
| EPS Basic Total Ops | -1.24 | -4.50 | -1.87 | -1.25 | -21.57 |
| EPS Basic Continuous Ops | -1.24 | -4.50 | -1.87 | -1.25 | -21.54 |
| EPS Diluted Total Ops | -1.24 | -4.50 | -1.87 | -1.25 | -21.57 |
| EPS Diluted Continuous Ops | -1.24 | -4.50 | -1.87 | -1.25 | -21.54 |
| EBITDA(a) | $-32,746 | $-10,387 | $-7,672 | $-3,982 | $56,127 |